Thiais, France

Didier Rouy

This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharmaceuticals Inc.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Didier Rouy. Retrieved from https://idiyas.com/inventor/didier-rouy-lfk4uveg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 50(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Didier Rouy

Introduction

Didier Rouy is a notable inventor based in Thiais, France. He has made significant contributions to the field of biotechnology, particularly in the development of transgenic organisms. His work focuses on creating innovative solutions for human health challenges.

Latest Patents

Didier Rouy holds a patent for a transgenic rabbit that expresses a functional human lipoprotein (a). This invention involves a transgenic rabbit that contains genomic DNA sequences encoding apolipoprotein (a) and apolipoprotein B polypeptides. These components are capable of combining to produce lipoprotein (a). The patent also outlines a process for creating such a rabbit and its use in identifying compounds effective in treating human diseases associated with Lp(a) expression.

Career Highlights

Rouy has worked with Aventis Pharmaceuticals Inc., where he has been able to apply his expertise in biotechnology. His innovative approach has contributed to advancements in the understanding and treatment of diseases related to lipoprotein (a).

Collaborations

Didier Rouy has collaborated with notable colleagues, including Nicolas Duverger and Florence Emmanuel. These partnerships have enhanced the research and development efforts in his field.

Conclusion

Didier Rouy exemplifies the spirit of innovation in biotechnology through his groundbreaking work on transgenic organisms. His contributions have the potential to significantly impact human health and disease treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…